Avinger, Inc. (AVGR)
| Market Cap | 71.97M |
| Revenue (ttm) | 10.40M |
| Net Income (ttm) | -20.68M |
| Shares Out | 95.35M |
| EPS (ttm) | -0.24 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,035,438 |
| Open | 0.740 |
| Previous Close | 0.755 |
| Day's Range | 0.704 - 0.750 |
| 52-Week Range | 0.214 - 2.670 |
| Beta | 1.75 |
| Analysts | Buy |
| Price Target | 2.50 (+250.9%) |
| Est. Earnings Date | Nov 9, 2021 |
About AVGR
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as th...
Financial Performance
In 2020, Avinger's revenue was $8.76 million, a decrease of -4.05% compared to the previous year's $9.13 million. Losses were -$19.01 million, -2.28% less than in 2019.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for Avinger stock is "Buy." The 12-month stock price forecast is 2.50, which is an increase of 250.88% from the latest price.
News
Ground-Breaking Clinical Data from INSIGHT Trial Presented at VIVA
Study Outcomes Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical...
Avinger To Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15
REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system ...
Avinger OCT-Guided Technologies Featured at AMP 2021
REDWOOD CITY, CA / ACCESSWIRE / August 16, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system fo...
Avinger: Q2 Earnings Insights
Shares of Avinger (NASDAQ:AVGR) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 77.78% year over year to ($0.04), which were in line with th...
Avinger Reports Second Quarter 2021 Financial Results
Pantheris Sales and Tigereye™ Expansion Drive 91% Year-Over-Year Revenue Growth REDWOOD CITY, CA / ACCESSWIRE / August 10, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company m...
Earnings Outlook For Avinger
Avinger (NASDAQ:AVGR) releases its next round of earnings this Tuesday, August 10. Here is Benzinga's essential guide to Avinger's Q2 earnings report.
Avinger Announces 510(k) Filing for New Lightbox 3 Imaging Console
Smaller Footprint, Improved User Experience and Lower Cost to Drive Adoption REDWOOD CITY, CA / ACCESSWIRE / August 9, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marke...
Avinger to Announce Second Quarter 2021 Results on August 10, 2021
REDWOOD CITY, CA / ACCESSWIRE / July 27, 2021 / Avinger, Inc. (Nasdaq:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for di...
Avinger Files US Application For New Pantheris In-Stent Restenosis Indication
Avinger Inc (NASDAQ: AVGR) has submitted a 510(k) application to the FDA for a new Pantheris clinical indication for the treatment of in-stent restenosis (ISR) in the lower extremity arteries. To submis...
Avinger Announces 510(k) Filing for New Pantheris In-Stent Restenosis Indication
REDWOOD CITY, CA / ACCESSWIRE / July 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
5 Red-Hot Stocks Under $10 With Big Upside Potential
While most of Wall Street focuses on large-cap and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.
Avinger Announces Key Opinion Leader Presentations at Vascular Conferences in Germany
REDWOOD CITY, CA / ACCESSWIRE / June 28, 2021 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...
Avinger Announces Presentations by Key Opinion Leaders at New Cardiovascular Horizons Annual Conference
REDWOOD CITY, CA / ACCESSWIRE / June 7, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
Avinger Announces Issuance and Allowance of Seven U.S. Patents
REDWOOD CITY, CA / ACCESSWIRE / May 25, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
Avinger To Present at the Oppenheimer MedTech, Tools & Diagnostics Summit May 26
REDWOOD CITY, CA / ACCESSWIRE / May 17, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
Avinger Reports First Quarter 2021 Financial Results
13% Year-over-Year Revenue Growth Driven by Tigereye™ Commercial Launch and Pantheris SV Sales Growth REDWOOD CITY, CA / ACCESSWIRE / May 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medica...
3 Hot Penny Stocks To Buy With Analysts Expecting Up To 383%
Penny stocks to buy according to top Wall Street analysts The post 3 Hot Penny Stocks To Buy With Analysts Expecting Up To 383% appeared first on Penny Stocks to Buy, Picks, News and Information | Penny...
Avinger to Announce First Quarter 2021 Results on May 6, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 26, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for d...
Hot Penny Stocks To Watch In April 2021 If Biotech Is A Focus
List Of Penny Stocks To Watch Right Now The post Hot Penny Stocks To Watch In April 2021 If Biotech Is A Focus appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
New Publications Highlight Clinical Benefits of Avinger PAD Therapies
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
Avinger Achieves Commercial Milestone with More Than 100 Accounts Using Pantheris SV
REDWOOD CITY, CA / ACCESSWIRE / April 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for...
Avinger Provides Update on Tigereye(TM) Commercial Launch
REDWOOD CITY, CA / ACCESSWIRE / April 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for ...
Target Top-Line Growth and Compelling Patient Outcomes with Avinger
It's been reported that AVGR stock is popular among Robinhood traders. That's fine, but it's more important to see the company's potential.
Avinger: Q4 Earnings Insights
Avinger (NASDAQ:AVGR) reported Q4 results on Thursday afternoon. Quarterly Results Earnings per share were up 87.93% over the past year to ($0.07), which missed the estimate of ($0.06).